|
Report Date : |
27.07.2012 |
IDENTIFICATION DETAILS
|
Name : |
TAI YU CHEMICAL & PHARMACEUTICAL CO., LTD. |
|
|
|
|
Registered Office : |
No.1, Alley 13, Lane 11, Yun San Rd., Chu Tung Hsinchu |
|
|
|
|
Country : |
Taiwan |
|
|
|
|
Date of Incorporation : |
20.11.1973 |
|
|
|
|
Com. Reg. No.: |
47066452 |
|
|
|
|
Legal Form : |
Joint Stock Company |
|
|
|
|
Line of Business : |
Manufacturing and sales of medicinal chemicals, botanical drugs and herbs |
|
|
|
|
No. of Employees : |
About 200 Employees |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
Taiwan |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
|
Company Name: |
|
|
Supplied Name: |
|
|
Trading Address: |
No.1, Alley 13, Lane 11, Yun San Rd., Chu
Tung Hsinchu Taiwan |
|
Supplied Address: |
1 Alley 13 Lane 11 Yun san Rd Chutung Chen
Hsinchu Hsien 310 Taiwan |
|
Telephone Number: |
+886-3-582-6655 |
|
Fax Number: |
+886-3-582-2389 |
|
E-mail: |
Notes: The exact address is as above.
|
Credit Opinion: |
|
Registered Name: |
Tai Yu Chemical & Pharmaceutical Co., Ltd. |
|
Registered Address: |
No.1, Alley 13, Lane 11, Yun San Rd., Chu Tung Hsinchu Taiwan |
|
Date of Foundation: |
1973-11-20 |
|
Registration Number: |
47066452 |
|
Registry: |
MOEA Central Office |
|
Registered Capital: |
NTD 367,700,000
(USD 12,281,180) (As of 2012.07, 1 NTD = 0.0334 USD) |
|
Paid-up Capital: |
NTD 245,960,000 (USD 8,215,064) |
|
Legal Representatives: |
Shanjie Lin |
|
Legal Form: |
|
|
Principal Activities: |
Manufacturing and sales
of medicinal chemicals, botanical drugs and herbs |
|
Staff: |
|
|
Listed at Stock
Exchange: |
|
|
Date of Last
Annual Return: |
Subject was incorporated on 1973-11-20 with registered
number 47066452 as Joint Stock Company in Taiwan.
|
Name |
Subscription Shares |
|
Shanjie Lin |
10,070 |
|
Peiling Lin |
3,300 |
The information
above is that of subject’s major shareholders.
Related Companies
|
1 |
|
|
Name |
Hua Yu (Wu Xi)
Pharmaceutical Co., Ltd |
|
Address |
43 Mashan Mei
Liang Road, Binhu District, Wuxi City, Jiangsu Province, China |
|
2 |
|
|
Name |
Tai Yu (Wu Xi)
Pharmaceutical Co., Ltd |
|
Address |
No 1, 43 Mashan Mei
Liang Road, Binhu District, Wuxi City, Jiangsu Province, China |
Core
Management
Directors
|
1 |
|
|
Name |
Shanjie Lin |
|
Position |
Chairman |
|
2 |
|
|
Name |
Jinlian Xu |
|
Position |
Director |
|
3 |
|
|
Name |
Yanming Zheng |
|
Position |
Director |
|
4 |
|
|
Name |
Peiling Lin |
|
Position |
Supervisor |
Personnel
Structure
|
Total Employees |
About 200 Employees |
Offices
& Factories
|
|
Headquarters |
|
Add |
No.1, Alley 13, Lane 11, Yun San Rd., Chu Tung Hsinchu Taiwan |
Production
Information
l
Subject is engaged in
manufacturing of medicinal chemicals, botanical drugs and herbs, etc.
l
It is introduced that subject’s
Taiwan factory is about 10,000 square meters.
Purchase
Information
l
The registered activities of subject:
|
Business Code |
Details |
|
C110010 |
Manufacturing of drink |
|
C199990 |
Manufacturing of other uncategorized food |
|
C801030 |
Manufacturing of precision chemical materials |
|
C802041 |
Manufacturing of western medicine |
|
C802060 |
Manufacturing of animal medicine |
|
C802100 |
Manufacturing of cosmetic |
|
C802990 |
Manufacturing of other chemical |
|
CF01011 |
Manufacturing of medical device |
|
F102040 |
Wholesale of drink |
|
F102170 |
Wholesale of food and groceries |
|
F107990 |
Wholesale of other chemical |
|
F108021 |
Wholesale of western medicine |
|
F108031 |
Wholesale of medical device |
|
F108040 |
Wholesale of cosmetic |
|
F203010 |
Retail of food, drink and groceries |
|
F207990 |
Retail of other chemical |
|
F208021 |
Retail of western medicine |
|
F208031 |
Retail of medical device |
|
F208040 |
Retail of cosmetic |
|
F401010 |
International trade business |
|
ZZ99999 |
Besides licensed business, all other business
items those are not banned or restricted. |
l
The raw materials for production are purchased from
both home and abroad.
l
Subject is engaged in
sales of medicinal chemicals, botanical drugs and herbs, etc.
l
Subject’s major customers
are hospital and clinic, etc.
l
Subject’s products are mostly sold in Taiwan
domestic market.
l
Subject obtained the certification of GMP.
Major products
sold
|
|
Product |
|
1 |
Antibiotics (Penicillins, Cephalosporins,
Aminoglycosides, Other Antibiotics) |
|
2 |
Antibacterial Agents |
|
3 |
Antipyretics Analgesics & Anti-inflammatories |
|
4 |
Antigout Agents |
|
5 |
Adrenocortical Hormones |
|
6 |
Antitussives Expectorants & Antiasthmatics |
|
7 |
Common Cold preparations |
|
8 |
Antihistamine Agents |
|
9 |
Vitamins |
|
10 |
Hepatotonics & Antidotes |
|
11 |
Antihypertensive Agents |
|
12 |
Cardiotonics & Diuretics |
|
13 |
Anti-dizziness Agents |
|
14 |
Cerebral Metabolic Agents |
|
15 |
Spasmolytics |
|
16 |
Remedies of Peptic Ulcer |
|
17 |
Gastrointestinal Agents |
|
18 |
Antiemetics |
|
19 |
Hemostatic Agents |
|
20 |
Autonomic Agents |
|
21 |
Anti-Diabetic Agents |
|
22 |
Hormone Preparations |
|
23 |
Oxytocics |
|
24 |
Water, Nutrients and Electrolytes |
|
25 |
Metabolics & Electrolytes |
|
26 |
Local Anesthetics |
|
27 |
Dermatics |
Import and export
right:
|
Import right |
Yes |
|
Export right |
Yes |
Purchase
Domestic Purchase (Taiwan and Mainland, China)
|
Payment Terms |
Proportion |
|
|
Raw materials |
COD, CBD, etc |
100% |
Foreign Purchase
|
Payment Terms |
Proportion |
|
|
Raw materials |
CBD, etc |
100% |
Sales
Domestic Markets (Taiwan and Mainland, China)
|
Sales Terms |
Proportion |
|
|
Medicinal chemicals and
drugs |
COD, CBD, etc |
100% |
Export
|
Sales Terms |
Proportion |
|
|
Medicinal chemicals and
drugs |
CBD, etc |
100% |
Notes: Subject’s settlement for export is generally in USD
Subject has no obligations to disclose its financial statements to the
third party according to the relevant policy in Taiwan and the only source from
which we can obtain the information is the subject itself.
Subject’s relevant staff Mr. Zhang declined to disclose its financials
citing the grounds of company’s confidentiality; from other source we can not
obtain the relevant information, either.
|
Name |
Taipei Bank |
Mortgage
No chattel mortgage record of subject has been found within the recent 3
months.
Lawsuit
Up to date of
reporting, no existing or latent litigation of the subject has been found.
|
Name |
Mr. Zhang |
|
Department |
Sales Department |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.55.95 |
|
|
1 |
Rs.86.56 |
|
Euro |
1 |
Rs.67.95 |
INFORMATION DETAILS
|
Report
Prepared by : |
PRL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.